NCT06916065: A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
- State
- Completed
- Phase
- Phase 1
- People
- 188 taking part
- Started
- 9 Apr 2025
- Primary completion
- 19 Jan 2026
- Arms
- Eloralintide and Tirzepatide-Cohorts A-D
- Results
- None posted
- 8 Apr 2025: Trial registered
- 9 Apr 2025: Trial started
- 19 Jan 2026: Trial completed